Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
Ambrx Biopharma Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 69.01% |
| Axonics Inc | 77.16% |
| Harpoon Therapeutics Inc (DELISTED) | -- |
| Merck & Co Inc | 75.51% |
| RayzeBio inc (DELISTED) | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.85% |
| Return on Assets | -29.51% |
| Return on Invested Capital | -33.81% |
| Profit Margin (Quarterly) | -43.38K% |
| Operating Margin (Quarterly) | -48.35K% |
| Return on Net Operating Assets | -153.7% |